Search Contract Opportunities

INTENT TO SOLE SOURCE gPROMS Lyophilization Modeling Toolbox (or equal)   2

ID: FDA75F40126Q00155 • Type: Special Notice • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

The FDA / Center for Drug Evaluation and Research (CDER) / Office of Pharmaceutical Quality Research (OPQR) requires to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies.

Please review the attached Intent to Sole Source FDA-75F40126Q00155 document for more information.

Background
The United States Food and Drug Administration (FDA), specifically the Center for Drug Evaluation and Research (CDER) and the Office of Pharmaceutical Quality Research (OPQR), is seeking to acquire an advanced lyophilization process modeling and simulation platform. This initiative aims to enhance the study of emerging pharmaceutical manufacturing technologies. The FDA intends to award a sole source contract to Siemens Government Technologies, Inc., indicating that only one responsible source can meet the agency's requirements.

Work Details
The contractor shall provide a Lyophilization Modeling Toolbox with the following salient characteristics:
- Nonlinear Predictive Control (NL) for Lyophilization, optimized for high-performance computing to perform large-scale predictive modeling of lyophilization cycles.
- Operational Intelligence & Data Integration, including a base system capable of aggregating real-time operational data for 'Digital Twin' validation.
- High-Fidelity Dynamic Simulation, simulating transient process events using first-principles mathematical equations.
- Advanced Material & Thermodynamic Property Architecture for modeling complex pharmaceutical formulations.
- Automated Global System Analysis (GSA) tools for parameter estimation and sensitivity analysis.
- Customizable Modeling Environment & API for creating custom models and integrating with external data systems.
- Scalable Enterprise Access with flexible licensing types.
- Regulatory-Grade Maintenance and Support through a multi-year subscription model, including continuous software enhancement and technical support.
Additionally, the contractor must provide maintenance support via email/web conference, licenses including necessary upgrades, one day of project support, and access to online training materials.

Period of Performance
The contract will be performed over a 12-month period.

Place of Performance
The contract will be performed at the location specified by the FDA.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity appears to have a closely related prior contract with Siemens Industry Software under contract 75F40121P00258 for FLOWSHEET MODELING AND SIMULATION SOFTWARE LICENSE (valued at $106,055, with performance from 06/24/21 to 07/11/26). The current requirement seeks an advanced lyophilization process modeling and simulation platform (including dynamic simulation, predictive control, and data integration), which is consistent with a continuation or expansion of the earlier modeling/simulation software licensing into a more specialized lyophilization “toolbox” capability.

Overview

Response Deadline
June 2, 2026, 1:00 p.m. EDT Past Due
Posted
May 22, 2026, 3:17 p.m. EDT
Set Aside
None
Place of Performance
Silver Spring, MD 20993 United States
Source

Current SBA Size Standard
$47 Million
Pricing
Fixed Price
Est. Level of Competition
Sole Source
Est. Value Range
Experimental
$150,000 - $350,000 (AI estimate)
On 5/22/26 FDA Office of Acquisition and Grant Services issued Special Notice FDA75F40126Q00155 for INTENT TO SOLE SOURCE gPROMS Lyophilization Modeling Toolbox (or equal) due 6/2/26.
Primary Contact
Name
Terina Hicks   Profile
Phone
None

Documents

Posted documents for Special Notice FDA75F40126Q00155

Opportunity Assistant


AI Analysis

AI Generate

Opportunity Lifecycle

Procurement notices related to Special Notice FDA75F40126Q00155

Incumbent or Similar Awards

Contracts Similar to Special Notice FDA75F40126Q00155

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice FDA75F40126Q00155

Similar Active Opportunities

Open contract opportunities similar to Special Notice FDA75F40126Q00155

Experts for INTENT TO SOLE SOURCE gPROMS Lyophilization Modeling Toolbox (or equal)

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA Office of Acquisitions and Grants Services
FPDS Organization Code
7524-75FDA1
Source Organization Code
500035507
Last Updated
May 22, 2026
Last Updated By
terina.hicks@fda.hhs.gov
Archive Date
June 17, 2026